RxBio
Pre-clinicalDevelops medical countermeasures and vaccines for infectious diseases and biodefense threats.
Founded
2008
Focus
Infectious DiseaseVaccines
About
Develops medical countermeasures and vaccines for infectious diseases and biodefense threats.
Funding History
2Total raised: $12.5M
Series A$12MUndisclosedJan 15, 2023
Grant$500KNational Institutes of HealthMar 15, 2021
Company Info
TypePrivate
Founded2008
LocationJohnson City, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile